Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...

While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and ...

A NEW ‘Ozempic pill’ leads to faster weight loss than the popular ‘skinny jabs’, studies have suggested. The new weight loss ...